Our Team

Each Partner brings extensive industry knowledge, unrivaled relationships and substantial deal experience, resulting in a team of the industry's most sought after advisors

Steven Markovich

Steven Markovich is a Partner in Centerview’s technology team. He has over 20 years of investment banking experience and has advised software companies and financial sponsors on a broad range of M&A, equity and debt financings.

Select transactions include:
  • SAP’s sale of Qualtrics
  • Redzone’s sale to QAD
  • Servicemax’s sale to PTC
  • OpenText’s acquisition of Micro Focus
  • Solera’s acquisition of Spireon
  • Vista and Evergreen’s acquisition of Citrix
  • Azuga’s sale to Bridgestone
  • Thoma Bravo’s acquisition of QAD
  • Motus’ sale to Permira
  • Supplyframe’s sale to Siemens
  • THL’s acquisition of Bazaarvoice
  • Plex’s sale to Rockwell Automation
  • Arena’s sale to PTC
  • Flexera’s sale to Thoma Bravo
  • Omnitrac’s acquisition of Smartdrive
  • Thoma Bravo’s acquisition of Command Alkon
  • Francisco Partners’ acquisition of LogMeIn
  • PTC’s acquisition of Onshape
  • Salesforce’s acquisition of MapAnything
  • TomTom’s sale of its Telematics business to Bridgestone
  • Centrify’s sale to Thoma Bravo
  • Imprivata’s sale to Thoma Bravo
  • Telogis’ sale to Verizon
  • Sascar’s sale to Michelin
  • SAP’s acquisition of Sybase
Prior to joining Centerview in 2023, Steve spent over 18 years at Barclays and Lehman Brothers in New York. He was most recently Co-Head of Global Software at Barclays.

Steve has an MBA from the Tepper School of Business at Carnegie Mellon University and an undergraduate degree from the Stern School of Business at NYU.
Centerview Partners takes a “One Firm” approach to deliver unmatched intellectual capital and integrity to all of our clients. We have industry-leading expertise in:

Centerview is honored to partner with leading charitable organizations in active support of our charities:

  • Arts Connection
  • NY Cares
  • Bottomless Closet
Nexus Pharmaceuticals, Inc.
Announced: Q2 2024
Status: Pending

Exclusive financial advisor to Nexus on the sale of an injectable medicine manufacturing facility to Eli Lilly
View All
New York

Centerview Partners LLC

31 West 52nd Street

22nd Floor

New York, New York 10019

(212) 380-2650 | Tel
(212) 380-2651 | Fax

Centerview Partners UK LLP

1 Sherwood Street

6th Floor

London W1F 7BL

02074099700 | Tel
02074099704 | Fax

Centerview Partners France SCS

51 Avenue Hoche

Paris 75008

0180200620 | Tel
0180200621 | Fax
Menlo Park

Centerview Partners LLC

1302 El Camino Real

Suite 350

Menlo Park, California 94025

(650) 822-5800 | Tel
(650) 822-5801 | Fax
San Francisco

Centerview Partners LLC

555 California Street

Suite 4300

San Francisco, California 94104

(415) 400-0900 | Tel
(415) 400-0901 | Fax

Copyright © 2008 - 2024 Centerview Partners Holdings LP. All Rights Reserved. | Privacy and Other Notices

Centerview Partners LLC, member SIPC